Cargando…

An EMT-based risk score thoroughly predicts the clinical prognosis, tumor immune microenvironment and molecular subtypes of bladder cancer

BACKGROUND: Epithelial mesenchymal transition (EMT) is closely related to the occurrence, development, metastasis and antitumor immunity of tumors. However, comprehensive studies correlating EMT and prognosis, tumor microenvironment (TME) and molecular subtypes of bladder cancer (BLCA) are lacking....

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Zicheng, Cai, Zhiyong, Deng, Dingshan, Tong, Shiyu, Zu, Xiongbing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540509/ https://www.ncbi.nlm.nih.gov/pubmed/36211349 http://dx.doi.org/10.3389/fimmu.2022.1000321

Ejemplares similares

Cuproptosis depicts tumor microenvironment phenotypes and predicts precision immunotherapy and prognosis in bladder carcinoma
por: Li, Huihuang, et al.
Publicado: (2022)

Cuproptosis-related modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of kidney renal clear cell carcinoma
por: Cai, Zhiyong, et al.
Publicado: (2022)

Robust pyroptosis risk score guides the treatment options and predicts the prognosis of bladder carcinoma
por: Deng, Dingshan, et al.
Publicado: (2022)

A Robust Hypoxia Risk Score Predicts the Clinical Outcomes and Tumor Microenvironment Immune Characters in Bladder Cancer
por: Liu, Zhi, et al.
Publicado: (2021)

A Novel TGF-β Risk Score Predicts the Clinical Outcomes and Tumour Microenvironment Phenotypes in Bladder Cancer
por: Liu, Zhi, et al.
Publicado: (2021)

Molecular vasculogenic mimicry–Related signatures predict clinical outcomes and therapeutic responses in bladder cancer: Results from real-world cohorts
por: Zhang, Chunyu, et al.
Publicado: (2023)

5mC regulator-mediated molecular subtypes depict the hallmarks of the tumor microenvironment and guide precision medicine in bladder cancer
por: Hu, Jiao, et al.
Publicado: (2021)

TNF Family–Based Signature Predicts Prognosis, Tumor Microenvironment, and Molecular Subtypes in Bladder Carcinoma
por: Li, Huihuang, et al.
Publicado: (2022)

PMEPA1 Is a Prognostic Biomarker That Correlates With Cell Malignancy and the Tumor Microenvironment in Bladder Cancer
por: Qiu, Dongxu, et al.
Publicado: (2021)

ACER2 forms a cold tumor microenvironment and predicts the molecular subtype in bladder cancer: Results from real-world cohorts
por: Liu, Jinhui, et al.
Publicado: (2023)

Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer
por: Hu, Jiao, et al.
Publicado: (2021)

S100A5 Attenuates Efficiency of Anti‐PD‐L1/PD‐1 Immunotherapy by Inhibiting CD8(+) T Cell‐Mediated Anti‐Cancer Immunity in Bladder Carcinoma
por: Li, Huihuang, et al.
Publicado: (2023)

Molecular subtypes based on Wnt-signaling gene expression predict prognosis and tumor microenvironment in hepatocellular carcinoma
por: Xu, Weifeng, et al.
Publicado: (2022)

Identification and validation of an immune signature associated with EMT and metabolic reprogramming for predicting prognosis and drug response in bladder cancer
por: Zhang, Zhao, et al.
Publicado: (2022)

Thoroughly Remold the Localization and Signaling Pathway of TLR22
por: Ji, Jianfei, et al.
Publicado: (2020)

BCAT2 Shapes a Noninflamed Tumor Microenvironment and Induces Resistance to Anti‐PD‐1/PD‐L1 Immunotherapy by Negatively Regulating Proinflammatory Chemokines and Anticancer Immunity
por: Cai, Zhiyong, et al.
Publicado: (2023)

Identification of cuproptosis -related subtypes, the development of a prognosis model, and characterization of tumor microenvironment infiltration in prostate cancer
por: Jin, Liang, et al.
Publicado: (2022)

Gene Expression Classifier Reveals Prognostic Osteosarcoma Microenvironment Molecular Subtypes
por: Song, Yi-Jiang, et al.
Publicado: (2021)

Immune Microenvironment in Glioblastoma Subtypes
por: Chen, Zhihong, et al.
Publicado: (2018)

A glycosylation risk score comprehensively assists the treatment of bladder neoplasm in the real-world cohort, including the tumor microenvironment, molecular and clinical prognosis
por: Liu, Jinhui, et al.
Publicado: (2023)

A cancer-associated fibroblast subtypes-based signature enables the evaluation of immunotherapy response and prognosis in bladder cancer
por: Qin, Yiming, et al.
Publicado: (2023)

SUMOylation Pattern Predicts Prognosis and Indicates Tumor Microenvironment Infiltration Characterization in Bladder Cancer
por: Xia, Qi-Dong, et al.
Publicado: (2022)

Serum CXCL13 Level is Associated with Tumor Progression and Unfavorable Prognosis in Penile Cancer
por: Mo, Miao, et al.
Publicado: (2020)

CLASP2 is involved in the EMT and early progression after transurethral resection of the bladder tumor
por: Zhu, Bisong, et al.
Publicado: (2017)

Cervical cancer immune infiltration microenvironment identification, construction of immune scores, assisting patient prognosis and immunotherapy
por: Yao, Shijie, et al.
Publicado: (2023)

Comprehensive FGFR3 alteration-related transcriptomic characterization is involved in immune infiltration and correlated with prognosis and immunotherapy response of bladder cancer
por: Xu, Ting, et al.
Publicado: (2022)

Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy
por: Li, Ruiyu, et al.
Publicado: (2021)

THEM6: A Novel Molecular Biomarker Predicts Tumor Microenvironment, Molecular Subtype, and Prognosis in Bladder Cancer
por: Zhao, Xu, et al.
Publicado: (2022)

Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer
por: Wang, Jinyan, et al.
Publicado: (2022)

Identification of cuproptosis-related subtypes, characterization of immune microenvironment infiltration, and development of a prognosis model for osteoarthritis
por: Nong, Jiao, et al.
Publicado: (2023)

A hypoxia risk score for prognosis prediction and tumor microenvironment in adrenocortical carcinoma
por: Deng, Yuanyuan, et al.
Publicado: (2022)

Stemness Subtypes and Scoring System Predict Prognosis and Efficacy of Immunotherapy in Soft Tissue Sarcoma
por: Gu, Hui-Yun, et al.
Publicado: (2022)

Cuproptosis-Related Risk Score Predicts Prognosis and Characterizes the Tumor Microenvironment in Hepatocellular Carcinoma
por: Zhang, Zhen, et al.
Publicado: (2022)

Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer
por: Lu, Hongcheng, et al.
Publicado: (2022)

Identification of cuproptosis-related subtypes, characterization of tumor microenvironment infiltration, and development of a prognosis model in breast cancer
por: Li, Zhi, et al.
Publicado: (2022)

Identification of copper metabolism and cuproptosis-related subtypes for predicting prognosis tumor microenvironment and drug candidates in hepatocellular carcinoma
por: Liu, Xianglong, et al.
Publicado: (2022)

Identification of disulfidptosis-related subtypes, characterization of tumor microenvironment infiltration, and development of a prognosis model in breast cancer
por: Liang, Jiahui, et al.
Publicado: (2023)

Molecular subtypes, tumor microenvironment infiltration characterization and prognosis model based on cuproptosis in bladder cancer
por: Zhang, Heping, et al.
Publicado: (2023)

Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer
por: Wang, Zhi, et al.
Publicado: (2021)

Thoroughness
por: Dotterer, L. P.
Publicado: (1885)

Cannot write session to /tmp/vufind_sessions/sess_gadki8kfjs53jjkb10i320515k